India Cryptococcosis Market Size & Outlook, 2026-2034


India Cryptococcosis Market Insights

  • Based on Reed Intelligence findings, the India Cryptococcosis Market reached USD 21.16 Million in 2025 and is estimated to attain USD 38.5 Million by 2034.
  • From 2026 to 2034, the India market is expected to grow at a steady CAGR of 6.85%.
  • Within the By Drug Class category, Azoles dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Azoles is forecasted to deliver the fastest growth, positioning it as the most lucrative By Drug Class segment.

Other Key Findings


  • As of 2025, India held 3.11% of the global Cryptococcosis Market size.
  • By 2034, United States is anticipated to capture the largest share of the global Cryptococcosis Market.
  • In Asia Pacific, China is expected to lead the regional Cryptococcosis Market size by 2034.
  • India will remain the fastest-growing market in Asia Pacific, reaching USD 38.4 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 21.16 Million
Market Size In 2034 USD 38.5 Million
Largest segment Azoles
Units Revenue in USD Million
CAGR 6.85% (2026-2034)
Segmnetation Covered
By Drug Class
  1. Azoles
  2. Polyenes
  3. Flucytosine
  4. Combination Therapy
By Indication
  1. Cryptococcal Meningitis
  2. Pulmonary Cryptococcosis
  3. Disseminated Cryptococcosis
By Route of Administration
  1. Oral
  2. Intravenous
By End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends